SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
57,671,650
Total 13F shares
59,473,450
Share change
+324,270
Total reported value
$1,874,807,260
Put/Call ratio
0%
Price per share
$31.52
Number of holders
292
Value change
+$9,630,477
Number of buys
160
Number of sells
114

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
15%
from 13D/G
9,684,552
$317,169,082 31 Mar 2025
VANGUARD GROUP INC
13F
Company
11%
6,163,892
$201,867,464 31 Mar 2025
13F
ARMISTICE CAPITAL, LLC
13F
Company
9%
5,196,000
$170,169,000 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5%
2,903,727
$95,094,446 31 Mar 2025
13F
MACQUARIE GROUP LTD
13F
Company
4.7%
2,699,667
$88,414,000 31 Mar 2025
13F
STATE STREET CORP
13F
Company
3.7%
2,145,350
$70,260,213 31 Mar 2025
13F
Stephens Investment Management Group LLC
13F
Company
3%
1,738,482
$56,935,286 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.7%
1,585,722
$51,932,396 31 Mar 2025
13F
LOOMIS SAYLES & CO L P
13F
Company
2.5%
1,440,644
$47,182,000 31 Mar 2025
13F
GW&K Investment Management, LLC
13F
Company
2.4%
1,382,441
$45,275,000 31 Mar 2025
13F
Polar Capital Holdings Plc
13F
Company
2.4%
1,362,340
$44,616,635 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
1,326,619
$43,456,798 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
2%
1,135,312
$37,181,469 31 Mar 2025
13F
Aristotle Capital Boston, LLC
13F
Company
1.5%
872,688
$28,580,522 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.4%
824,155
$26,991,076 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.3%
746,149
$24,436,380 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.2%
706,772
$23,146,784 31 Mar 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
1.2%
672,518
$22,024,965 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.1%
649,838
$21,282,241 31 Mar 2025
13F
ASHFORD CAPITAL MANAGEMENT INC
13F
Company
0.98%
566,556
$18,554,709 31 Mar 2025
13F
Pictet Asset Management Holding SA
13F
Company
0.94%
543,913
$17,566,806 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.92%
530,631
$17,378,165 31 Mar 2025
13F
Sofinnova Investments, Inc.
13F
Company
0.9%
520,678
$17,052,205 31 Mar 2025
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.89%
515,889
$16,895,365 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.88%
509,360
$16,681,541 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.84%
483,079
$15,820,838 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.81%
467,881
$15,323,103 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.78%
452,684
$14,825,413 31 Mar 2025
13F
Krensavage Asset Management, LLC
13F
Company
0.75%
431,986
$14,148,000 31 Mar 2025
13F
Pacer Advisors, Inc.
13F
Company
0.7%
403,628
$13,218,817 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.67%
385,501
$12,625,167 31 Mar 2025
13F
Tributary Capital Management, LLC
13F
Company
0.58%
331,979
$10,872,312 31 Mar 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.55%
318,903
$10,444,073 31 Mar 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.53%
306,322
$10,032,047 31 Mar 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.47%
269,480
$8,701,509 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.45%
260,061
$8,516,998 31 Mar 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.44%
256,406
$8,397,297 31 Mar 2025
13F
UBS Group AG
13F
Company
0.43%
250,316
$8,197,849 31 Mar 2025
13F
SEI INVESTMENTS CO
13F
Company
0.42%
244,099
$7,994,165 31 Mar 2025
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
0.38%
219,731
$7,196,190 31 Mar 2025
13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC
13F
Company
0.35%
201,965
$6,614,354 31 Mar 2025
13F
THIRD AVENUE MANAGEMENT LLC
13F
Company
0.33%
189,493
$6,205,896 31 Mar 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.3%
172,259
$5,641,482 31 Mar 2025
13F
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
0.29%
166,504
$5,453,020 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.29%
165,323
$5,414,302 31 Mar 2025
13F
GREAT LAKES ADVISORS, LLC
13F
Company
0.28%
163,580
$5,357,245 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.28%
161,514
$5,289,584 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.26%
152,352
$4,989,526 31 Mar 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.26%
149,489
$4,895,765 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.25%
144,494
$4,732,179 31 Mar 2025
13F

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2025

As of 30 Jun 2025, SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by 292 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,473,450 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Stephens Investment Management Group LLC, GEODE CAPITAL MANAGEMENT, LLC, and LOOMIS SAYLES & CO L P. This page lists 292 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
289
Q2 2025 holders
292
Holder diff
3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .